These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 30380941)

  • 1. Public Understanding and Awareness of Isotretinoin Use and Safety in Al Ahsa, Eastern Saudi Arabia.
    Younis NS; Al-Harbi NY
    Ther Innov Regul Sci; 2019 Sep; 53(5):618-622. PubMed ID: 30380941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge on the Use of Isotretinoin and Its Side Effects and Awareness towards Saudi FDA-Pregnancy Prevention Program among the Female Acne Patients: A Northern Saudi Study.
    Alshaalan ZM
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363566
    [No Abstract]   [Full Text] [Related]  

  • 3. Community pharmacists' knowledge of isotretinoin safety.
    Alrwisan AA; Alshammari TM; Tahir KW; Aleissa FM; Aljadhey HS
    Saudi Med J; 2014 Jan; 35(1):81-4. PubMed ID: 24445895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
    Ahmad HM
    Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions about oral isotretinoin treatment.
    Tugrul Ayanoglu B; Demirdag HG; Yalici Armagan B; Bezirgan O
    Dermatol Ther; 2019 May; 32(3):e12873. PubMed ID: 30868702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acne with oral isotretinoin in patients with cystic fibrosis.
    Perera E; Massie J; Phillips RJ
    Arch Dis Child; 2009 Aug; 94(8):583-6. PubMed ID: 19465582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
    Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
    Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatologists' level of compliance with the prescription guidelines of isotretinoin for females of childbearing potential.
    AlGhamdi KM; Khurram H; Asiri YA; Mandil A
    Int J Dermatol; 2011 Sep; 50(9):1094-8. PubMed ID: 22126870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of clinical adverse effects and laboratory alterations in patients with acne vulgaris treated with oral isotretinoin.
    Brito Mde F; Sant'Anna IP; Galindo JC; Rosendo LH; Santos JB
    An Bras Dermatol; 2010; 85(3):331-7. PubMed ID: 20676466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris?
    Verros CD; Rallis E
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1270-1. PubMed ID: 17894728
    [No Abstract]   [Full Text] [Related]  

  • 11. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne.
    Kaymak Y; Ilter N
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1256-60. PubMed ID: 17062042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotretinoin for acne vulgaris.
    al-Khawajah MM
    Int J Dermatol; 1996 Mar; 35(3):212-5. PubMed ID: 8655243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotretinoin updates.
    On SC; Zeichner J
    Dermatol Ther; 2013; 26(5):377-89. PubMed ID: 24099068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser safety in isotretinoin use: online survey of public perception.
    AlKhowailed M; AlWayili S; Altalhab S; AlJasser MI; Al-Hargan A
    J Dermatolog Treat; 2022 Mar; 33(2):778-781. PubMed ID: 32538248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
    Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
    JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observational retrospective study evaluating the effects of oral isotretinoin in keloids and hypertrophic scars.
    Guadanhim LR; Gonçalves RG; Bagatin E
    Int J Dermatol; 2016 Nov; 55(11):1255-1258. PubMed ID: 27419807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and adverse events of oral isotretinoin for acne: a systematic review.
    Vallerand IA; Lewinson RT; Farris MS; Sibley CD; Ramien ML; Bulloch AGM; Patten SB
    Br J Dermatol; 2018 Jan; 178(1):76-85. PubMed ID: 28542914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing the oral isotretinoin skin side effects: efficacy of 8% omega-ceramides, hydrophilic sugars, 5% niacinamide cream compound in acne patients.
    Cannizzaro MV; Dattola A; Garofalo V; Del Duca E; Bianchi L
    G Ital Dermatol Venereol; 2018 Apr; 153(2):161-164. PubMed ID: 29564872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotretinoin for acne and rosacea.
    Watson KD; Miest RY; Tollefson MM
    Semin Cutan Med Surg; 2016 Jun; 35(2):79-86. PubMed ID: 27416313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.